Experimental Hematology
Volume 30, Issue 10 , Pages 1162-1169 , October 2002

Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias

  • Shimei Gong

      Affiliations

    • Departments of Pediatrics, University of Kentucky, Lexington, Ky., USA
    • ,
  • Xin Lu

      Affiliations

    • Departments of Pediatrics, University of Kentucky, Lexington, Ky., USA
    • ,
  • Yongsheng Xu

      Affiliations

    • Departments of Pediatrics, University of Kentucky, Lexington, Ky., USA
    • ,
  • Carol F. Swiderski

      Affiliations

    • Departments of Medicine, University of Kentucky, Lexington, Ky., USA
    • ,
  • Craig T. Jordan

      Affiliations

    • Departments of Medicine, University of Kentucky, Lexington, Ky., USA
    • ,
  • Jeffrey A. Moscow

      Affiliations

    • Corresponding Author InformationOffprint requests to: Jeffrey A. Moscow, M.D., Department of Pediatrics, University of Kentucky, 740 S. Limestone, Room J457, Lexington, KY 40536, USA
    • Departments of Pediatrics, University of Kentucky, Lexington, Ky., USA

Received 8 January 2002 ,Revised 28 May 2002 ,Accepted 24 June 2002.

References 

  1. Koepsell H. Organic cation transporters in intestine, kidney, liver and brain. Annu Rev Physiol. 1998;60:243
  2. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature. 1994;372:549
  3. Zhang L, Brett CM, Giacomini KM. Role of organic cation transporters in drug absorption and elimination. Annu Rev Pharmacol Toxicol. 1998;38:431
  4. Giacomini KM. Membrane transporters in drug disposition. J Pharmacokinet Biopharm. 1997;25:731
  5. Gorboulev V, Ulzheimer JC, Akhoundova A, et al.  Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 1997;16:871
  6. Koepsell H, Gorboulev V, Arndt P. Molecular pharmacology of organic cation transporters in kidney. J Membr Biol. 1999;167:103
  7. Okuda M, Saito H, Urakami Y, Takano M, Inui K. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun. 1996;224:500
  8. Zhang L, Dresser MJ, Chun JK, Babbitt PC, Giacomini KM. Cloning and functional characterization of a rat renal organic cation transporter isoform (rOCT1A). J Biol Chem. 1997;272:16548
  9. Kekuda R, Prasad PD, Wu X, et al.  Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem. 1998;273:15971
  10. Wu X, Kekuda R, Huang W, et al.  Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem. 1998;273:32776
  11. Dhillon U, Shenton J, Cook V, Harper P, Watson-Macdonnel J, Ito S. The expression of the human organic cation transporter hOCT1 in mammary gland. Clin Pharmacol Ther. 1999;65:205
  12. Tamai I, Yabuuchi H, Nezu J, et al.  Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 1997;419:107
  13. Yabuuchi H, Tamai I, Nezu J, et al.  Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther. 1999;289:768
  14. Wu X, Prasad PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun. 1998;246:589
  15. Thompson JD, Higgins DG, Gibson TJ. Clustal w (improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice). Nucleic Acids Res. 1994;22:4673
  16. Moscow JA, Schneider ES, Ivy SP, Cowan KH. Multidrug resistance. In:  Pinedo HM,  Longo DL,  Chabner BA editor. Cancer chemotherapy and biological response modifiers. Annual 17. New York: Elsevier; 1997; 139p
  17. Moscow JA, Gong M, He R, et al.  Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 1995;55:3790
  18. Moscow JA, Connolly T, Myers T, Paull K, Cheng CC, Cowan KH. Reduced folate carrier gene expression in transfected and non-selected cell lines. Int J Cancer. 1997;72:184
  19. Huhn D, von Schilling C, Wilhelm M, et al.  Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood. 2001;98:1326
  20. Kreitman RJ, Wilson WH, Bergeron K, et al.  Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med. 2001;345:241
  21. Bunjes D, Buchmann I, Duncker C, et al.  Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome (results of a phase I-II study). Blood. 2001;98:565
  22. Sievers EL, Larson RA, Stadtmauer EA, et al.  Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol. 2001;19:3244

PII: S0301-472X(02)00901-3

Experimental Hematology
Volume 30, Issue 10 , Pages 1162-1169 , October 2002

Article Tools

* Image Usage & Resolution